Switch to the original Schedule Online view

Community Schedule

Enter at least 4 characters

0 matches for: '2559730' in the Therapeutic Groups

1 results showing for: '2559730'

- Only on a controlled drug form
- No patient co-payment payable
- Safety medicine; prescriber may determine dispensing frequency
  • Tab controlled-release 20 mg
    • Brand Fully subsidised brand. OxyContin
    • Pharmacode2613832
    • Subsidy $13.25
    • Measure / Qty per 28
    • Brand Fully subsidised brand. Oxycodone Sandoz
    • Pharmacode2559730
    • Subsidy $3.49
    • Measure / Qty per 20
    • Brand Fully subsidised brand. Oxycodone Sandoz S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2609142
    • Subsidy $5.38
    • Measure / Qty per 50
    • Brand Fully subsidised brand. Oxycodone Sandoz S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2609150
    • Subsidy $10.75
    • Measure / Qty per 100
    Oxycodone Sandoz to be Principal Supply on 1 June 2022
    (OxyContin Tab controlled-release 20 mg to be delisted 01 June 2022)
    (Oxycodone Sandoz S29 Tab controlled-release 20 mg to be delisted 01 June 2022)

For Anti-inflammatory NSAIDS refer to MUSCULOSKELETAL, page 110

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • B Bolded Pharmacode means that the product is to be delisted soon
  • Sole Subsidised Supply